Literature DB >> 20591981

The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism.

Andrew A Dwyer1, Frances J Hayes, Lacey Plummer, Nelly Pitteloud, William F Crowley.   

Abstract

CONTEXT AND
OBJECTIVE: Adult-onset idiopathic hypogonadotropic hypogonadism (AHH) is a rare disorder characterized by an isolated failure of gonadotropin secretion occurring after an otherwise normal sexual maturation in men. This study aims to examine the etiology and long-term natural history of this disorder. DESIGN AND
SETTING: Long-term follow up, including detailed clinical, biochemical, and genetic examinations, were performed and compared with those at diagnosis. PATIENTS: Patients included 10 men with AHH [serum testosterone (T) <125 ng/dl].
INTERVENTIONS: Overnight neuroendocrine studies, semen fluid analyses, and genetic screening were performed (KAL1, FGFR1, PROK2, PROKR2, NELF, TAC3, TACR3, and GNRH1) over a decade of longitudinal follow up.
RESULTS: Follow-up evaluations were conducted 10.6 +/- 5.9 yr after initial studies and revealed that the clinical characteristics and seminal fluid analyses of AHH men (body mass index, 28.8 +/- 4.1 vs. 27.0 +/- 4.3 kg/m(2); testicular volume, 18 +/- 6 vs. 19 +/- 6 ml) do not change over a decade with no spontaneous reversals. Several men exhibited some variability in their endogenous GnRH-induced LH secretory patterns, including emergence of endogenous pulsatility in three individuals. However, all remained hypogonadal (T < or =130 ng/dl). A single heterozygous DNA sequence change in PROKR2 (V317L) was identified, although this rare sequence variant did not prove to be functionally abnormal in vitro. Seven days of pulsatile GnRH therapy in this subject nearly normalized his serum T, supporting that the site of the defect is hypothalamic and not pituitary.
CONCLUSIONS: 1) AHH in men appears to be a long-lasting condition. 2) Although minor changes in the abnormal pattern of endogenous GnRH-induced LH secretion occurred in some AHH patients, all remained frankly hypogonadal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20591981      PMCID: PMC2936052          DOI: 10.1210/jc.2010-0245

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies.

Authors:  F J Hayes; D J McNicholl; D Schoenfeld; E E Marsh; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

Review 2.  Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.

Authors:  S B Seminara; F J Hayes; W F Crowley
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

3.  Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Authors:  S E Antonarakis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.

Authors:  N de Roux; J Young; M Misrahi; R Genet; P Chanson; G Schaison; E Milgrom
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility.

Authors:  L B Nachtigall; P A Boepple; F P Pralong; W F Crowley
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

6.  Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin.

Authors:  B Couzinet; J Young; S Brailly; Y Le Bouc; P Chanson; G Schaison
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

Review 7.  Gonadotroph cell pituitary adenomas.

Authors:  P J Snyder
Journal:  Endocrinol Metab Clin North Am       Date:  1987-09       Impact factor: 4.741

8.  Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.

Authors:  R B Perkins; J E Hall; K A Martin
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

9.  Pituitary and gonadal responsiveness is enhanced during GnRH-induced puberty.

Authors:  D I Spratt; W F Crowley
Journal:  Am J Physiol       Date:  1988-05

10.  Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings.

Authors:  E Thodou; S L Asa; G Kontogeorgos; K Kovacs; E Horvath; S Ezzat
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

View more
  10 in total

1.  Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History.

Authors:  Andrew A Dwyer; Niraj R Chavan; Hilana Lewkowitz-Shpuntoff; Lacey Plummer; Frances J Hayes; Stephanie B Seminara; William F Crowley; Nelly Pitteloud; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1.

Authors:  Yee-Ming Chan; Sarabeth Broder-Fingert; Sophia Paraschos; Risto Lapatto; Margaret Au; Virginia Hughes; Suzy D C Bianco; Le Min; Lacey Plummer; Felecia Cerrato; Adelaide De Guillebon; I-Hsuan Wu; Fazal Wahab; Andrew Dwyer; Susan Kirsch; Richard Quinton; Timothy Cheetham; Metin Ozata; Svetlana Ten; Jean-Pierre Chanoine; Nelly Pitteloud; Kathryn A Martin; Raphael Schiffmann; Hetty J Van der Kamp; Shahla Nader; Janet E Hall; Ursula B Kaiser; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

Review 3.  Approach to male infertility and induction of spermatogenesis.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2013-09       Impact factor: 5.958

4.  Kisspeptin resets the hypothalamic GnRH clock in men.

Authors:  Yee-Ming Chan; James P Butler; Nancy E Pinnell; François P Pralong; William F Crowley; Chen Ren; Kenneth K Chan; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

5.  Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.

Authors:  Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

Review 6.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

Review 7.  Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.

Authors:  Maria I Stamou; Neoklis A Georgopoulos
Journal:  Metabolism       Date:  2017-11-03       Impact factor: 8.694

8.  Genetics of isolated hypogonadotropic hypogonadism: role of GnRH receptor and other genes.

Authors:  Karges Beate; Neulen Joseph; de Roux Nicolas; Karges Wolfram
Journal:  Int J Endocrinol       Date:  2011-12-21       Impact factor: 3.257

Review 9.  Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Authors:  Baris Gencer; Marco Bonomi; Maria Pia Adorni; Cesare R Sirtori; François Mach; Massimiliano Ruscica
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514

Review 10.  Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.

Authors:  Yujun Liu; Xu Zhi
Journal:  Reprod Sci       Date:  2021-07-06       Impact factor: 2.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.